Research & Development

日本天堂网av在线观看av天天堂在线观看日本天天色经济日报刊文:划清保健食品与“神药”界限

發布時間︰

第四十二章   ***日本天堂网av在线观看   “淼淼,你別沖動。”陸昔年看向林徵羽,對方輕輕地握住他的手。av天天堂在线观看日本   8L︰陸亦鴻書粉+1,年糕那版確實不錯,失眠的時候听會有意想不到的效果哦!   陸爸爸敗下陣來, 陸昔年看著聊天消息笑出聲, 然後悄悄往林徵羽瞄了一眼, 他也正在用微信發消息,完全不知道自己已經成為此時的話題中心。天天色   正和陸昔年此時此刻的心情一模一樣。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo